Virtu Financial LLC Age X Therapeutics, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$0.33 - $0.74 $9,474 - $21,246	28,712 New	28,712 $11,000
Q3 2022 Nov 07, 2022	BUY	$0.55 - $0.74 $11,324 - $15,236	20,590 New	20,590 $12,000
Q1 2022 May 17, 2022	SELL	$0.65 - $1.2 $21,654 - $39,976	-33,314 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.53 - $1.09 $17,656 - $36,312	33,314 New	33,314 $36,000
Q3 2020 Dec 11, 2020	SELL	$0.79 - $1.52 $12,061 - $23,207	-15,268 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$0.68 - $1.13 $10,382 - $17,252	15,268 New	15,268 $14,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.